Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
|+ | |+ | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Disease Name}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Disease Name}} | ||
! style="background: #4479BA; width: 150px;" | | ! style="background: #4479BA; width: 150px;" | Causes | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| History and Symptoms}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| History and Symptoms}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Physical Examination Findings}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Physical Examination Findings}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG Characteristics}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG Characteristics}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| ECG view}} | ||
!Prognosis | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left"| | ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular tachycardia | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 22: | Line 15: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left"| | ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Ventricular fibrillation | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 33: | Line 23: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Asystole | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 44: | Line 31: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulseless electrical activity | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 55: | Line 39: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" |Pulmonary embolism | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 66: | Line 47: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="left" | | ! style="padding: 5px 5px; background: #DCDCDC;" align="left" | | ||
Line 73: | Line 55: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" | | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 89: | Line 63: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|} | |} | ||
<references /> | <references /> |
Revision as of 18:36, 16 January 2020
Disease Name | Causes | History and Symptoms | Physical Examination Findings | ECG Characteristics | ECG view | Prognosis |
---|---|---|---|---|---|---|
Ventricular tachycardia | ||||||
Ventricular fibrillation | ||||||
Asystole | ||||||
Pulseless electrical activity | ||||||
Pulmonary embolism | ||||||
Disease Name | Age of Onset | Gender Preponderance | Signs/Symptoms | Imaging Feature(s) | Macroscopic Feature(s) | Microscopic Feature(s) | Laboratory Findings(s) | Other Feature(s) | ECG view |
---|---|---|---|---|---|---|---|---|---|